Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2024
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,637
-19.96%
|
$15,559,817
$1141.49 P/Share
|
|
Aug 13
2024
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+22.65%
|
$7,980,000
$399.66 P/Share
|
|
Aug 13
2024
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
500
-1.0%
|
-
|
|
Aug 12
2024
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
900
-1.76%
|
-
|
|
Aug 08
2024
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,197
-1.6%
|
$5,633,548
$1084.01 P/Share
|
|
Aug 07
2024
|
Jason Pitofsky VP Controller |
SELL
Open market or private sale
|
Direct |
487
-10.38%
|
$521,090
$1070.0 P/Share
|
|
Aug 07
2024
|
Jason Pitofsky VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
487
+9.41%
|
$181,164
$372.46 P/Share
|
|
Aug 02
2024
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
18,441
-24.71%
|
$20,156,013
$1093.49 P/Share
|
|
Aug 02
2024
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
23,638
+24.05%
|
$13,119,090
$555.67 P/Share
|
|
Aug 02
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
756
-35.36%
|
$842,940
$1115.0 P/Share
|
|
Aug 02
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
756
+26.12%
|
$280,476
$371.4 P/Share
|
|
Aug 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,137
-8.08%
|
$1,205,220
$1060.86 P/Share
|
|
Aug 01
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,137
+7.48%
|
$422,964
$372.46 P/Share
|
|
Aug 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$108,200
$1082.36 P/Share
|
|
Jul 11
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,866
-4.69%
|
$2,030,208
$1088.95 P/Share
|
|
Jul 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$105,900
$1059.06 P/Share
|
|
Jul 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,137
-8.08%
|
$1,190,439
$1047.11 P/Share
|
|
Jul 01
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,137
+7.48%
|
$422,964
$372.46 P/Share
|
|
Jun 24
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
11,084
-21.78%
|
$11,749,040
$1060.13 P/Share
|
|
Jun 24
2024
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
14,450
+22.12%
|
$8,019,750
$555.67 P/Share
|
|
Jun 24
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
756
-35.36%
|
$802,872
$1062.0 P/Share
|
|
Jun 24
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
756
+26.12%
|
$280,476
$371.4 P/Share
|
|
Jun 14
2024
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,535
-52.62%
|
$1,596,400
$1040.0 P/Share
|
|
Jun 14
2024
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,535
+34.48%
|
$959,375
$625.6 P/Share
|
|
Jun 12
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
16,149
-42.55%
|
$16,455,831
$1019.06 P/Share
|
|
Jun 12
2024
|
Leonard S Schleifer President & CEO |
BUY
Conversion of derivative security
|
Indirect |
1,000
+50.0%
|
-
|
|
Jun 11
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
9,064
-7.23%
|
$9,199,960
$1015.66 P/Share
|
|
Jun 10
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Bona fide gift
|
Indirect |
1,608
-100.0%
|
-
|
|
Jun 10
2024
|
George Yancopoulos President and Chief Scientific |
BUY
Bona fide gift
|
Indirect |
37,900
+40.34%
|
-
|
|
Jun 10
2024
|
George Yancopoulos President and Chief Scientific |
SELL
Bona fide gift
|
Indirect |
75,799
-100.0%
|
-
|
|
Jun 06
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
787
-1.21%
|
$798,805
$1015.02 P/Share
|
|
Jun 05
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
827
-37.44%
|
$836,097
$1011.0 P/Share
|
|
Jun 05
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
827
+27.24%
|
$314,260
$380.95 P/Share
|
|
Jun 03
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$99,100
$991.02 P/Share
|
|
Jun 03
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,138
-8.09%
|
$1,115,240
$980.16 P/Share
|
|
Jun 03
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,138
+7.48%
|
$423,336
$372.46 P/Share
|
|
May 28
2024
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,172
-45.89%
|
$1,141,528
$974.86 P/Share
|
|
May 28
2024
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,172
+31.45%
|
$732,500
$625.6 P/Share
|
|
May 21
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,865
-5.1%
|
$1,853,810
$994.9 P/Share
|
|
May 17
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Direct |
22,830
-2.33%
|
$22,350,570
$979.64 P/Share
|
|
May 16
2024
|
George Yancopoulos President and Chief Scientific |
SELL
Open market or private sale
|
Direct |
50,000
-0.51%
|
$48,600,000
$972.93 P/Share
|
|
May 15
2024
|
George Yancopoulos President and Chief Scientific |
SELL
Open market or private sale
|
Direct |
50,000
-0.23%
|
$48,850,000
$977.45 P/Share
|
|
May 15
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Direct |
10,941
-0.27%
|
$10,765,944
$984.03 P/Share
|
|
May 14
2024
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.9%
|
$24,475,000
$979.63 P/Share
|
|
May 13
2024
|
Leonard S Schleifer President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
144,433
-25.0%
|
$140,966,608
$976.79 P/Share
|
|
May 13
2024
|
Leonard S Schleifer President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
203,204
+26.02%
|
$81,078,396
$399.66 P/Share
|
|
May 03
2024
|
George L Sing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
877
-3.09%
|
$826,134
$942.53 P/Share
|
|
May 03
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.59%
|
$826,000
$413.33 P/Share
|
|
May 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$90,100
$901.47 P/Share
|
|
May 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.9%
|
$222,250
$889.41 P/Share
|